Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life

被引：18

作者：

Baysal, Mehmet ^{[1
]}

Umit, Elif G. ^{[1
]}

Kirkizlar, Hakki Onur ^{[1
]}

Ozdover, Ali Caner ^{[1
]}

Demir, Ahmet Muzaffer ^{[1
]}

机构：

[1] Trakya Univ, Dept Hematol, Fac Med, Edirne, Turkey

来源：

TURKISH JOURNAL OF HEMATOLOGY | 2019年 / 36卷 / 01期

关键词：

Hereditary hemorrhagic telangiectasia; Thalidomide; Epistaxis; Quality of life;

D O I：

10.4274/tjh.galenos.2018.2018.0190

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominantly inherited disorder characterized by bleeding episodes. These episodes tend to happen spontaneously and reduce the quality of life. Patients are often unresponsive to local measures. With the pathophysiological role of angiogenesis in HHT, antiangiogenic drugs including thalidomide are used to control bleeding episodes. In our study, we evaluated 6 patients with HHT, calculating their Epistaxis Severity Score (ESS) and performing a quality of life assessment with the 36-Item Short Form Health Survey Questionnaire (SF-36), and we studied the alterations of these evaluations with thalidomide treatment. Three patients were male and three were female. Mean age was 60.50 years. No side effects were observed during the treatment period. Improvements of certain SF-36 dimensions including physical functioning, physical component summary, and mental component summary and of the ESS were observed after treatment. Thalidomide may be effective to control bleeding episodes with a reasonable tolerance profile in patients with HHT.

引用

页码：43 / 47

页数：5

共 19 条

[1] Clinical Practice Guidelines From the AABB Red Blood Cell Transfusion Thresholds and Storage [J].

Carson, Jeffrey L. ;

Guyatt, Gordon ;

Heddle, Nancy M. ;

Grossman, Brenda J. ;

Cohn, Claudia S. ;

Fung, Mark K. ;

Gernsheimer, Terry ;

Holcomb, John B. ;

Kaplan, Lewis J. ;

Katz, Louis M. ;

Peterson, Nikki ;

Ramsey, Glenn ;

Rao, Sunil V. ;

Roback, John D. ;

Shander, Aryeh ;

Tobian, Aaron A. R. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (19) :2025-2035

[2] Life expextancy of parents with Hereditary Haemorrhagic Telangiectasia [J].

de Gussem, E. M. ;

Edwards, C. P. ;

Hosman, A. E. ;

Westermann, C. J. J. ;

Snijder, R. J. ;

Faughnan, M. E. ;

Mager, J. J. .

ORPHANET JOURNAL OF RARE DISEASES, 2016, 11

[3] Thalidomide for Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia: A Preliminary Study [J].

Fang, Jia ;

Chen, Xiaomeng ;

Zhu, Bijun ;

Ye, Haibo ;

Zhang, Weitian ;

Guan, Jian ;

Su, Kaiming .

OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2017, 157 (02) :217-221

[4] International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia [J].

Faughnan, M. E. ;

Palda, V. A. ;

Garcia-Tsao, G. ;

Geisthoff, U. W. ;

McDonald, J. ;

Proctor, D. D. ;

Spears, J. ;

Brown, D. H. ;

Buscarini, E. ;

Chesnutt, M. S. ;

Cottin, V. ;

Ganguly, A. ;

Gossage, J. R. ;

Guttmacher, A. E. ;

Hyland, R. H. ;

Kennedy, S. J. ;

Korzenik, J. ;

Mager, J. J. ;

Ozanne, A. P. ;

Piccirillo, J. F. ;

Picus, D. ;

Plauchu, H. ;

Porteous, M. E. M. ;

Pyeritz, R. E. ;

Ross, D. A. ;

Sabba, C. ;

Swanson, K. ;

Terry, P. ;

Wallace, M. C. ;

Westermann, C. J. J. ;

White, R. I. ;

Young, L. H. ;

Zarrabeitia, R. .

JOURNAL OF MEDICAL GENETICS, 2011, 48 (02) :73-87

[5] The Subjective Experience of Patients Diagnosed with Hereditary Hemorrhagic Telangiectasia: a Qualitative Study [J].

Geerts, Laura ;

Fantini-Hauwel, Carole ;

Brugalle, Elodie ;

Boute, Odile ;

Frenois, Frederic ;

Defrance, Lydie ;

Manouvrier-Hanu, Sylvie ;

Petit, Florence ;

Antoine, Pascal .

JOURNAL OF GENETIC COUNSELING, 2017, 26 (03) :612-619

[6] How to manage patients with hereditary haemorrhagic telangiectasia [J].

Geisthoff, Urban W. ;

Nguyen, Ha-Long ;

Roeth, Alexander ;

Seyfert, Ulrich .

BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (04) :443-452

[7] Medical treatment of epistaxis in hereditary hemorrhagic telangiectasia: an evidence-based review [J].

Halderman, Ashleigh A. ;

Ryan, Matthew W. ;

Clark, Christopher ;

Sindwani, Raj ;

Reh, Douglas D. ;

Poetker, David M. ;

Invernizzi, Rosangela ;

Marple, Bradley F. .

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2018, 8 (06) :713-728

[8] An Epistaxis Severity Score for Hereditary Hemorrhagic Telangiectasia [J].

Hoag, Jeffrey B. ;

Terry, Peter ;

Mitchell, Sally ;

Reh, Douglas ;

Merlo, Christian A. .

LARYNGOSCOPE, 2010, 120 (04) :838-843

[9]

Hosman AE, 2015, RHINOLOGY, V53, P340, DOI [10.4193/Rhin14.289, 10.4193/Rhino14.289]

[10] Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study [J].

Invernizzi, Rosangela ;

Quaglia, Federica ;

Klersy, Catherine ;

Pagella, Fabio ;

Ornati, Federica ;

Chu, Francesco ;

Matti, Elina ;

Spinozzi, Giuseppe ;

Plumitallo, Sara ;

Grignani, Pierangela ;

Olivieri, Carla ;

Bastia, Aella ;

Bellistri, Francesca ;

Danesino, Cesare ;

Benazzo, Marco ;

Balduini, Carlo L. .

LANCET HAEMATOLOGY, 2015, 2 (11) :E465-E473

← 1 2 →